Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of Accessible Air Travel

Core Viewpoint - Biogen Inc. and Delta Flight Products are collaborating to enhance air travel accessibility for passengers with reduced mobility, particularly those using wheelchairs, aiming to create a more equitable flying experience [1][2]. Group 1: Collaboration Details - The partnership will involve community events to gather insights from individuals with rare disease mobility restrictions, focusing on their travel experiences and needs [2]. - The first event will take place at the Cure SMA's 2024 Annual SMA Conference from June 6-9, 2024, in Austin, Texas, where feedback will be collected and shared publicly [2][3]. Group 2: Innovations and Products - Delta Flight Products has developed a prototype airplane seat that allows passengers to remain in their own wheelchairs during the flight, addressing a significant gap in travel accessibility [3][4]. - The innovative seat design includes features for comfort and safety, such as adjustable headrests and tray tables, and has received the APEX 2024 Innovation Award for Best Cabin [4]. Group 3: Company Backgrounds - Biogen is a leading biotechnology company focused on innovative treatments for patients with neuromuscular diseases, emphasizing independence and accessibility [5]. - Delta Flight Products specializes in aircraft interior solutions, providing engineering and manufacturing services to enhance airline cabin designs [8].